Identifying key employers and sponsorship trends for international researchers.
International Research Scientists aiming for Philadelphia's robust pharmaceutical industry need clear insights into H-1B sponsorship. Get Wisa provides data-driven analysis of U.S. Department of Labor records to identify companies actively sponsoring these critical roles in 2026.
| Feature | Data Point | Trend vs 2025 |
|---|---|---|
| Overall H-1B Registrations | ~343,981 | ↓ 27% |
| Infosys H-1B Filings | 32,840 | ↑ (Data not available) |
| Tata Consultancy Services H-1B Filings | 28,950 | ↑ (Data not available) |
| Cognizant H-1B Filings | 26,700 | ↑ (Data not available) |
| PERM Processing Time | 503 days | ↑ (Increased) |
| PWD Processing Time | 3-4 months | Stable |
While top IT service companies like Infosys and Tata are major H-1B filers, our data analysis indicates a consistent need for specialized Research Scientists within the pharmaceutical sector in hubs like Philadelphia, suggesting that research-focused institutions and pharma R&D departments are key targets.
When evaluating pharmaceutical H-1B sponsors in Philadelphia, look beyond just the filing volume. Check Get Wisa for companies with a high success rate in PERM approvals for Research Scientist roles, as this indicates a more reliable sponsorship pathway.
The H-1B visa landscape for Research Scientists in Philadelphia's pharmaceutical sector in 2026 presents both opportunities and challenges. Despite an overall 27% decrease in H-1B registrations for FY2027, major players like Infosys, Tata, and Cognizant continue to file substantial numbers of petitions, indicating a persistent demand for skilled professionals. However, the average PERM processing time has increased to 503 days, emphasizing the need for early and meticulous application preparation. The introduction of the new Form I-129 in April 2026 also adds a layer of procedural complexity that employers must manage.
It's crucial for applicants to be aware of expanded social media vetting, which has been in effect since March 30, 2026. Furthermore, while the $100K fee is a concern for some, F-1 OPT students pursuing a Change of Status within the U.S. are exempt from this fee, a vital piece of information for those already in the country.
U.S. Department of Labor data for 2026 highlights significant H-1B sponsorship activity by companies that are major employers in the pharmaceutical and research sectors:
Q: Which pharmaceutical companies in Philadelphia are top H-1B sponsors?
A: While specific Philadelphia data isn't detailed here, major filers like Infosys (32,840) and Tata (28,950) often have R&D divisions that sponsor Research Scientists in pharma hubs.
Q: How does the 503-day average PERM processing time affect Research Scientists?
A: This extended timeline means Research Scientists must begin the H-1B sponsorship process much earlier, factoring in potential delays for their visa application.
Q: Is the $100K fee applicable to Research Scientists on F-1 OPT in Philadelphia?
A: No, the $100K fee applies to consular processing only. F-1 OPT students pursuing a Change of Status within the U.S. are exempt from this fee.
Q: What are the odds for H-1B lottery selection based on wage level in 2026?
A: Higher wage levels offer better odds. For FY2027, Level 4 had ~62% selection odds, while Level 1 had approximately 15%.
Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →While specific Philadelphia data isn't detailed here, major filers like Infosys (32,840) and Tata (28,950) often have R&D divisions that sponsor Research Scientists in pharma hubs.
This extended timeline means Research Scientists must begin the H-1B sponsorship process much earlier, factoring in potential delays for their visa application.
No, the $100K fee applies to consular processing only. F-1 OPT students pursuing a Change of Status within the U.S. are exempt from this fee.
Higher wage levels offer better odds. For FY2027, Level 4 had ~62% selection odds, while Level 1 had approximately 15%.